Glanzmann's thrombasthenia proposed optimal management during surgery and delivery

被引:19
作者
Bell, JA [1 ]
Savidge, GF [1 ]
机构
[1] St Thomas Hosp, Haemophilia Reference Ctr, Ctr Haemostasis & Thrombosis, London SE1 7EH, England
关键词
thrombasthenia; platelet refractoriness; surgery; pregnancy; rVIIa (Novoseven (R));
D O I
10.1177/107602960300900213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glanzmann's thrombasthenia (GT) is an autosomal recessive disorder of platelet function. Conventional management is by platelet transfusion, given before invasive interventions. Alloimmunization resulting in platelet refractoriness and an unpredictable response to platelet infusion have provided particular management difficulties in the past. More recently recombinant (r)VIIa (Novoseven((R))) has a valuable role in the treatment of platelet function disorders. Treatment of a patient with GT during two pregnancies and spinal surgery is reported. An algorithm is presented to provide a structured and consistent approach to treatment.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [41] Thromboelastography with platelet mapping to guide anesthetic management of emergency cesarean delivery in a patient with thrombasthenia: a case report
    Chieko Akinaga
    Shingo Kawashima
    Yuji Suzuki
    Masako Matsumoto
    Yoshiki Nakajima
    JA Clinical Reports, 9
  • [42] Triple jeopardy: A case of Glanzmann's thrombasthenia with anti-GPIIb-IIIa antibodies and HPA incompatibility resulting in stillbirth
    Soni, Puja
    Mantri, Shruti
    Prabhudesai, Aniket
    Patil, Rucha
    Shanmukhaiah, Chandrakala
    Shetty, Shrimati
    THROMBOSIS RESEARCH, 2019, 181 : 141 - 144
  • [43] Perioperative management of Glanzmann's syndrome: how we did it!
    Depner, Christian
    Schmid, Roger
    Kirchhoff, Philipp
    Oertli, Daniel
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 283 - 284
  • [44] Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia
    Poon, Man-Chiu
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 655 - 664
  • [45] Constitutional thrombocytopathies (Glanzmann's thrombasthenia and Bernard-Soulier syndrome) from the initial description to the development of new antithrombotic agents
    Caen, J
    Bellucci, S
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1998, 182 (07): : 1493 - 1503
  • [46] Immunisation against αllbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation GIy540Asp on β3
    Wihadmadyatami, Hevi
    Roeder, Lida
    Berghoefer, Heike
    Bein, Gregor
    Heidinger, Kathrin
    Sachs, Ulrich J.
    Santoso, Sentot
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (02) : 262 - 271
  • [47] Optimal Delivery of Pain Management in Schwannomatosis: A Literature Review
    Hino, Utaro
    Tamura, Ryota
    Toda, Masahiro
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2025, 21 : 61 - 68
  • [48] Optimal care of inhibitor patients during surgery
    Vermylen, J
    Peerlinck, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 61 : 15 - 17
  • [49] Esmolol's Role in Hemodynamic Management During Pheochromocytoma Surgery: A Comprehensive Review
    Konjety, Pavithra
    Chakole, Vivek
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [50] Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation
    Wessel, Ann E.
    Mogensen, Kris M.
    Rohr, Frances
    Erick, Miriam
    Neilan, Edward G.
    Chopra, Sameer
    Levy, Harvey L.
    Gray, Kathryn J.
    Wilkins-Haug, Louise
    Berry, Gerard T.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2015, 39 (07) : 875 - 879